GlassScriptPhysician profile
Matthew Daniel Herring
NPI 1295224525
$11,840.56
in general payments reported to CMS, 2019-2025
8 companies · $821 in 2025
The $821 reported for 2025 was more than what 82% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $5,608 · 2022: $3,925 · 2023: $754 · 2024: $733 · 2025: $821.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,308.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,307.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Theratechnologies INC. | $8,414.61 | 2021-2023 | Egrifta, Trogarzo |
| Viiv Healthcare Company | $2,165.53 | 2021-2025 | Dovato, Rukobia, Cabenuva |
| Gilead Sciences, INC. | $925.05 | 2021-2025 | Biktarvy |
| Merck Sharp & Dohme LLC | $148.36 | 2021-2025 | Pifeltro, Delstrigo, Isentress |
| Janssen Biotech, INC. | $136.45 | 2023 | Symtuza |
| Novo Nordisk INC | $19.04 | 2021 | |
| Amgen INC. | $16.39 | 2021 | |
| Daiichi Sankyo INC. | $15.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Herring listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.